ARROWHEAD PHARMACEUTICALS, INC. Quarterly Marketable Securities, Current in USD from Q2 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q2 2011 to Q3 2022.
  • Arrowhead Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $0 -$127M -100% Sep 30, 2022 10-K 2022-11-28
Q2 2022 $0 -$126M -100% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $123M -$3.22M -2.56% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $126M +$40M +46.5% Dec 31, 2021 10-Q 2022-02-02
Q3 2021 $127M +$41.7M +49.1% Sep 30, 2021 10-K 2022-11-28
Q2 2021 $126M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $126M Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $86M Dec 31, 2020 10-Q 2021-02-04
Q3 2020 $85M Sep 30, 2020 10-K 2021-11-22
Q4 2014 $23.5M +$7.62M +47.9% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 $21.7M +$12.6M +140% Sep 30, 2014 10-Q 2015-02-09
Q2 2014 $23.8M +$19.8M +487% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $17.8M Mar 31, 2014 10-Q 2014-05-06
Q4 2013 $15.9M +$15.9M +28312% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 $9.03M +$8.92M +8379% Sep 30, 2013 10-K 2014-11-25
Q2 2013 $4.06M +$3.95M +3624% Jun 30, 2013 10-Q 2013-08-07
Q4 2012 $56K -$15.8K -22% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 $107K -$528K -83.2% Sep 30, 2012 10-K 2013-12-18
Q2 2012 $109K -$1.07M -90.7% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 $78.7K Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $71.8K Dec 31, 2011 10-Q 2012-02-09
Q3 2011 $635K Sep 30, 2011 10-K 2012-12-28
Q2 2011 $1.18M Jun 30, 2011 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.